Annual CFO
-$11.19 M
-$3.95 M-54.55%
31 December 2023
Summary:
Coya Therapeutics annual cash flow from operations is currently -$11.19 million, with the most recent change of -$3.95 million (-54.55%) on 31 December 2023. COYA annual CFO is now -186.65% below its all-time high of -$3.90 million, reached on 31 December 2021.COYA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$5.46 M
-$897.80 K-19.67%
30 September 2024
Summary:
Coya Therapeutics quarterly cash flow from operations is currently -$5.46 million, with the most recent change of -$897.80 thousand (-19.67%) on 30 September 2024. Over the past year, it has dropped by -$3.25 million (-146.44%). COYA quarterly CFO is now -354.50% below its all-time high of $2.15 million, reached on 31 March 2024.COYA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$10.12 M
-$3.25 M-47.21%
30 September 2024
Summary:
Coya Therapeutics TTM cash flow from operations is currently -$10.12 million, with the most recent change of -$3.25 million (-47.21%) on 30 September 2024. Over the past year, it has increased by +$1.05 million (+9.40%). COYA TTM CFO is now -409.91% below its all-time high of -$1.98 million, reached on 01 March 2022.COYA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COYA Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -54.5% | -146.4% | +9.4% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
COYA Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -186.7% | at low | -354.5% | at low | -409.9% | +9.6% |
5 y | 5 years | -186.7% | at low | -354.5% | at low | -409.9% | +9.6% |
alltime | all time | -186.7% | at low | -354.5% | at low | -409.9% | +9.6% |
Coya Therapeutics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$5.46 M(+19.7%) | -$10.12 M(+47.2%) |
June 2024 | - | -$4.56 M(-312.7%) | -$6.87 M(+32.7%) |
Mar 2024 | - | $2.15 M(-195.8%) | -$5.18 M(-53.7%) |
Dec 2023 | -$11.19 M | -$2.24 M(+1.1%) | -$11.19 M(+0.2%) |
Sept 2023 | - | -$2.22 M(-22.7%) | -$11.17 M(+5.9%) |
June 2023 | - | -$2.87 M(-25.8%) | -$10.55 M(+15.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$3.86 M(+73.8%) | -$9.12 M(+26.0%) |
Dec 2022 | -$7.24 M(+85.5%) | -$2.22 M(+39.7%) | -$7.24 M(+44.3%) |
Sept 2022 | - | -$1.59 M(+10.5%) | -$5.02 M(+46.5%) |
June 2022 | - | -$1.44 M(-27.4%) | -$3.42 M(+72.6%) |
Mar 2022 | - | -$1.98 M | -$1.98 M |
Dec 2021 | -$3.90 M | - | - |
FAQ
- What is Coya Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Coya Therapeutics?
- What is Coya Therapeutics annual CFO year-on-year change?
- What is Coya Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Coya Therapeutics?
- What is Coya Therapeutics quarterly CFO year-on-year change?
- What is Coya Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Coya Therapeutics?
- What is Coya Therapeutics TTM CFO year-on-year change?
What is Coya Therapeutics annual cash flow from operations?
The current annual CFO of COYA is -$11.19 M
What is the all time high annual CFO for Coya Therapeutics?
Coya Therapeutics all-time high annual cash flow from operations is -$3.90 M
What is Coya Therapeutics annual CFO year-on-year change?
Over the past year, COYA annual cash flow from operations has changed by -$3.95 M (-54.55%)
What is Coya Therapeutics quarterly cash flow from operations?
The current quarterly CFO of COYA is -$5.46 M
What is the all time high quarterly CFO for Coya Therapeutics?
Coya Therapeutics all-time high quarterly cash flow from operations is $2.15 M
What is Coya Therapeutics quarterly CFO year-on-year change?
Over the past year, COYA quarterly cash flow from operations has changed by -$3.25 M (-146.44%)
What is Coya Therapeutics TTM cash flow from operations?
The current TTM CFO of COYA is -$10.12 M
What is the all time high TTM CFO for Coya Therapeutics?
Coya Therapeutics all-time high TTM cash flow from operations is -$1.98 M
What is Coya Therapeutics TTM CFO year-on-year change?
Over the past year, COYA TTM cash flow from operations has changed by +$1.05 M (+9.40%)